Mia Campos, a 15-year-old gymnast from San Antonio, has found relief from the burden of managing her type 1 diabetes with the help of a new device called the “bionic pancreas.” The FDA recently approved this technology for use in diabetics, which simplifies insulin delivery by allowing users to input the size of their next meal and an AI algorithm to calculate and administer the correct amount of insulin.
Mia was diagnosed with diabetes at just five years old during a competition. She struggled to manage her blood sugar levels using traditional insulin pumps, which required constant programming and often malfunctioned. However, after consulting with her pediatric endocrinologist Dr. Jane Lynch, Mia was recommended the “bionic pancreas” as a solution. This device clips to Mia’s jeans and utilizes AI software to tailor insulin delivery based on glucose levels. Approved for use in individuals six years and older, it only requires one entry about the size of the next meal.
The “bionic pancreas” has been life-changing for Mia, who can now focus on her studies and gymnastics training without constantly worrying about carbohydrates and insulin levels. Dr. Lynch emphasizes that maintaining stable blood sugar levels through diet and exercise is crucial in addition to using this technology. Mia herself is excited about how this device will benefit many people, especially those with busy lifestyles who struggle with manual insulin management.
Overall, the “bionic pancreas” offers hope and relief for diabetics like Mia, allowing them to live more confidently and comfortably with their condition while simplifying insulin delivery through AI technology.
